Center on Health Equity & Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Press Releases

Product Approvals and Launches

Video

All Video Types

AJMC TV

Guidelines

Insights

OnLocation

Payer Perspectives

Peer Exchange

Post Conference Perspectives

Stakeholder Summit

Podcasts

Journals

All Journals

The American Journal of Managed Care

Population Health, Equity & Outcomes

Evidence-Based Oncology

About Supplements and Featured Publications

Supplements and Featured Publications Issues

Submit a Manuscript

Conferences

Conference Coverage

Conference Listing

Events

Institute for Value-Based Medicine

Patient-Centered Oncology Care

Resources

Interactive Tools

Formulary Central

Clinical Spotlight

Microsites

About AJMC

AJMC Staff

Anniversary

Seema Sonnad Award

Strategic Alliance Partners

Subscribe

 in 2023, where she produces content covering multiple disease states.

She has a BA in journalism from Seton Hall University. You can connect with Brooke on 

Articles

Hereditary ovarian cancer genes occur across diverse populations, supporting inclusive genetic testing.

Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups

Maggie is a senior editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.

She has a BA in English from Penn State University. You can connect with Maggie on 

Minimally invasive thymectomy for ocular myasthenia gravis (MG) enhanced complete stable remission rates and reduced surgical risks.

Minimally Invasive Thymectomy Shows Promise for Ocular MG

Sabrina McCrear is an assistant editor for 

 (AJMC®), which she joined in 2025. She produces written and video content across a range of disease areas and manages social media platforms for 

Sabrina holds a B.A. in Journalism with a minor in Biology from Howard University in Washington, D.C. You can connect with her on 

ACIP delayed the vote on the hepatitis B vaccine schedule amid ongoing controversy and misinformation surrounding vaccine safety and infant immunization.

ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy

Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.

She has a BA in English language and literature from Rutgers University. You can connect with Julia on 

Patients with stage I to IIIA NSCLC had lower 2- and 4-year mortality in states that expanded Medicaid coverage.

Medicaid Expansion Associated With Lower Mortality in NSCLC

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About

Contact

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

LinkedIn

Instagram

Specialty Area

Biosimilars

Cardiorenalmetabolic

Dermatology

Gastroenterology

Hematology

Hepatology

Immunology

Infectious Disease

Mental Health

Neurology

Obesity

Oncology

Ophthalmology

Pulmonology

Rare Disease

Respiratory

Rheumatology

Women's Health

Spotlight

Free In-Person Regional Events Focused on Oncology and Population Health

Topics

Digital Health

Formulary

Gene Therapy

Health Care Administration

Population Health

All Coverage

Event Coverage

Interviews

AJMC Journals

Author Forms

Authors

Nominate a Rising Leader

View

Employing Effective Multidisciplinary Care to Reduce the Burden of Myelodysplastic Syndrome 

Video Series

Key opinion leaders discuss the process of adapting MDS treatment strategies for optimal impact of care.

Adapting MDS Treatment Approach 

Videos

A panel of medical experts discuss the significance of collaborative care and key considerations in the treatment of myelodysplastic syndrome (MDS).

Ryan Haumschild, PharmD, MS, MBA, CPEL, opens the discussion by defining the MDS disease state. 

Myelodysplastic Syndrome (MDS) Overview 

An expert perspective on the variety of MDS subtypes is provided. 

Distinguishing Between Different MDS Subtypes 

Key opinion leaders discuss how patient quality of life is impacted by MDS treatment-associated challenges.

MDS-Related Complications Impacting Patient Quality of Life

Financial considerations in MDS treatment are discussed.

Economic Implications of MDS Management

Dr Haumschild leads a discussion surrounding the latest advancements in treatment algorithms for myelodysplastic syndrome.

Examining Treatment Algorithms for MDS 

Considerations for growth factor and stem cell transplant for patients with MDS is discussed. 

Growth Factor and Stem Cell Transplant Candidacy in MDS

A panel of experts discusses how novel agents are impacting the treatment landscape for patients diagnosed with MDS. 

Novel Agents Contributing to Evolving MDS Therapy Strategies 

Treatment compliance impacted by oral versus IV therapy is evaluated. 

Benefits of Oral Therapies In MDS Treatment Adherence 

Novel therapies in MDS treatment are evaluated by a panel of experts led by Dr Haumschild.

Novel Therapy Impact on Patient Quality of Life

Experts discuss how collaborative care drives optimal MDS treatment.

Multidisciplinary Care Driving Effective MDS Treatment

The panelists highlight key takeaways for payors involved in MDS treatment. 

Payor Considerations In MDS Management

Potential issues associated with insurance coverage and ways to navigate these challenges are discussed by medical experts.

Navigating Insurance-Related Challenges Associated With MDS Treatment

The panelists provide their final takeaways from the discussion surrounding treatment of MDS.

Key Considerations Surrounding MDS Treatment

Adapting MDS Treatment Approach

EP: 1.Myelodysplastic Syndrome (MDS) Overview

EP: 2.Distinguishing Between Different MDS Subtypes

EP: 3.MDS-Related Complications Impacting Patient Quality of Life

EP: 4.Economic Implications of MDS Management

EP: 5.Examining Treatment Algorithms for MDS

EP: 6.Growth Factor and Stem Cell Transplant Candidacy in MDS

EP: 7.Novel Agents Contributing to Evolving MDS Therapy Strategies

EP: 8.Benefits of Oral Therapies In MDS Treatment Adherence

EP: 9.Adapting MDS Treatment Approach

EP: 10.Novel Therapy Impact on Patient Quality of Life

EP: 11.Multidisciplinary Care Driving Effective MDS Treatment

EP: 12.Payor Considerations In MDS Management

EP: 13.Navigating Insurance-Related Challenges Associated With MDS Treatment

EP: 14.Key Considerations Surrounding MDS Treatment